A new approach to safeguard high standards and cost containment of stem cell transplantation in Germany
| Autor: | Norbert Schmitz, Ronald Walshe, Volker Diehl |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
medicine.medical_specialty
Economic growth Scrutiny Cost Control business.industry Public health Hematopoietic Stem Cell Transplantation Hematology medicine.disease Transplantation Medical services surgical procedures operative Safeguard Breast cancer Oncology Germany medicine Humans Stem cell business Cost containment |
| Zdroj: | Annals of Oncology. 10:609 |
| ISSN: | 0923-7534 |
| Popis: | Due to the tight budgets of the German public health insurances (PHI), new and expensive medical services have come under increased scrutiny since the mid-90s. Not surprisingly, this also applies to stem cell transplantation (SCT). In 1996, more than 250 hospitals applied for licence to perform SCT in Germany, raising fears of deteriorating standards and a cost explosion, especially as new indications such as breast cancer emerged. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|